News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia Michael O'Riordan May 30, 2024
News Daily News New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT Caitlin E. Cox July 08, 2022
News Daily News Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints L.A. McKeown June 06, 2022
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News Many ASCVD Patients Skimp on CV Meds Due to Costs: US Survey Caitlin E. Cox November 25, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Conference News ESC 2019 Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories Yael L. Maxwell September 06, 2019
News Daily News New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides Michael O'Riordan August 21, 2019
News Daily News A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November Yael L. Maxwell August 14, 2019
News Daily News European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs Shelley Wood December 18, 2018
News Daily News Los Cuidados Subóptimos de Mujeres con EAC se asocian a una Mayor Mortalidad a Largo Plazo Caitlin E. Cox February 28, 2016
News Daily News La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia Todd Neale July 13, 2015